Bank of America’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-257,485
| Closed | -$2.55M | – | 8205 |
|
|
2023
Q1 | $2.55M | Buy |
257,485
+216,520
| +529% | +$2.14M | ﹤0.01% | 4132 |
|
|
2022
Q4 | $408K | Buy |
40,965
+1,758
| +4% | +$13.1K | ﹤0.01% | 5520 |
|
|
2022
Q3 | $216K | Buy |
39,207
+1,554
| +4% | +$8.62K | ﹤0.01% | 5925 |
|
|
2022
Q2 | $137K | Buy |
37,653
+6,303
| +20% | +$29.8K | ﹤0.01% | 6319 |
|
|
2022
Q1 | $190K | Buy |
31,350
+26,473
| +543% | +$161K | ﹤0.01% | 6499 |
|
|
2021
Q4 | $41K | Buy |
+4,877
| New | +$42.6K | ﹤0.01% | 7295 |
|
|
2021
Q1 | – | Sell |
-406
| Closed | -$1K | – | 7918 |
|
|
2020
Q4 | $1K | Buy |
406
+136
| +50% | +$358 | ﹤0.01% | 7039 |
|
|
2020
Q3 | $0 | Buy |
270
+246
| +1,025% | +$371 | ﹤0.01% | 7298 |
|
|
2020
Q2 | $0 | Buy |
+24
| New | +$48 | ﹤0.01% | 7243 |
|
|
2019
Q4 | – | Sell |
-757
| Closed | -$2K | – | 7536 |
|
|
2019
Q3 | $2K | Buy |
+757
| New | +$2.4K | ﹤0.01% | 7026 |
|
|
2019
Q2 | – | Sell |
-2,123
| Closed | -$8K | – | 7510 |
|
|
2019
Q1 | $8K | Buy |
2,123
+748
| +54% | +$2.62K | ﹤0.01% | 6714 |
|
|
2018
Q4 | $5K | Buy |
+1,375
| New | +$6.79K | ﹤0.01% | 6776 |
|
|
2018
Q3 | – | Sell |
-394
| Closed | -$3K | – | 7539 |
|
|
2018
Q2 | $3K | Buy |
394
+209
| +113% | +$1.3K | ﹤0.01% | 6882 |
|
|
2018
Q1 | $1K | Buy |
+185
| New | +$1.17K | ﹤0.01% | 7009 |
|
|
2016
Q4 | – | Sell |
-7
| Closed | – | – | 7424 |
|
|
2016
Q3 | $0 | Buy |
+7
| New | +$93 | ﹤0.01% | 7441 |
|
|
2015
Q4 | – | Sell |
-386
| Closed | -$6K | – | 7531 |
|
|
2015
Q3 | $6K | Sell |
386
-9
| -2% | -$171 | ﹤0.01% | 6719 |
|
|
2015
Q2 | $8K | Buy |
395
+7
| +2% | +$692 | ﹤0.01% | 6670 |
|
|
2015
Q1 | $73K | Hold |
388
| – | – | ﹤0.01% | 5484 |
|
|
2014
Q4 | $84K | Sell |
388
-85
| -18% | -$19K | ﹤0.01% | 6009 |
|
|
2014
Q3 | $128K | Sell |
473
-1,391
| -75% | -$378K | ﹤0.01% | 5801 |
|
|
2014
Q2 | $570K | Buy |
1,864
+1
| +0.1% | +$317 | ﹤0.01% | 4487 |
|
|
2014
Q1 | $681K | Hold |
1,863
| – | – | ﹤0.01% | 4295 |
|
|
2013
Q4 | $611K | Buy |
1,863
+1
| +0.1% | +$367 | ﹤0.01% | 4582 |
|
|
2013
Q3 | $800K | Hold |
1,862
| – | – | ﹤0.01% | 4174 |
|
|
2013
Q2 | $631K | Buy |
+1,862
| New | +$700K | ﹤0.01% | 4519 |
|
Bank of America's APEN Position: Q2 2023 in Review
Bank of America sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 257,485 shares — an estimated $2.55M sold.
Bank of America first reported a position in APEN in Q2 2013 and held it in 25 quarters. The position peaked at $2.55M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Bank of America reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Bank of America sold 257,485 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $2.55M.
- Bank of America first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 25 quarters.
- Bank of America's Apollo Endosurgery, Inc. position peaked at $2.55M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.